1-[4-[3-(1H-indol-5-yl)-1-(4-methylphenyl)sulfonylpyrrolo[2,3-b]pyridin-5-yl]phenyl]piperidin-4-one
C33H28N4O3S — CID 176725953
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[4-[3-(1H-indol-5-yl)-1-(4-methylphenyl)sulfonylpyrrolo[2,3-b]pyridin-5-yl]phenyl]piperidin-4-one
1-[4-[3-(1H-indol-5-yl)-1-(4-methylphenyl)sulfonylpyrrolo[2,3-b]pyridin-5-yl]phenyl]piperidin-4-one (PubChem CID 176725953) has the molecular formula C33H28N4O3S and a molecular weight of 560.68 g/mol. Its IUPAC name is 1-[4-[3-(1H-indol-5-yl)-1-(4-methylphenyl)sulfonylpyrrolo[2,3-b]pyridin-5-yl]phenyl]piperidin-4-one.
Molecular Properties
| Compound Name | 1-[4-[3-(1H-indol-5-yl)-1-(4-methylphenyl)sulfonylpyrrolo[2,3-b]pyridin-5-yl]phenyl]piperidin-4-one |
|---|---|
| PubChem CID | 176725953 |
| Molecular Formula | C33H28N4O3S |
| Molecular Weight | 560.68 g/mol |
| Exact Mass | 560.19 |
| IUPAC Name | 1-[4-[3-(1H-indol-5-yl)-1-(4-methylphenyl)sulfonylpyrrolo[2,3-b]pyridin-5-yl]phenyl]piperidin-4-one |
| SMILES | Cc1ccc(S(=O)(=O)n2cc(-c3ccc4[nH]ccc4c3)c3cc(-c4ccc(N5CCC(=O)CC5)cc4)cnc32)cc1 |
| InChI | InChI=1S/C33H28N4O3S/c1-22-2-9-29(10-3-22)41(39,40)37-21-31(24-6-11-32-25(18-24)12-15-34-32)30-19-26(20-35-33(30)37)23-4-7-27(8-5-23)36-16-13-28(38)14-17-36/h2-12,15,18-21,34H,13-14,16-17H2,1H3 |
| InChIKey | MHHJHYGFGCZGFQ-UHFFFAOYSA-N |
| XLogP | 6.57 |
| TPSA | 88.06 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 41 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 560.68 |
| LogP ≤ 5 | 6.57 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 176725953 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.